Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | 2-Aminobenzotriazole REF: 3B-A1585CAS: 1614-11-5 | >98.0%(GC) | 90.00 €~534.00 € | Tue 25 Feb 25 |
![]() | 2H-Benzotriazol-2-amine REF: IN-DA001SG6CAS: 1614-11-5 | 98% | 120.00 €~590.00 € | Tue 04 Mar 25 |
![]() | 2H-Benzo[d][1,2,3]triazol-2-amine REF: 54-OR84807CAS: 1614-11-5 | 95% | 286.00 € | Wed 05 Mar 25 |
![]() | 2H-Benzo[d][1,2,3]triazol-2-amine REF: 10-F690272CAS: 1614-11-5 | 98% | 124.00 € | Fri 07 Mar 25 |
![]() | 2-Aminobenzotriazole REF: 3D-BAA61411CAS: 1614-11-5 | Min. 95% | - - - | Discontinued product |

2-Aminobenzotriazole
CAS:1614-11-5
Formula:
C6H6N4
Purity:
>98.0%(GC)
Color and Shape:
White to Almost white powder to crystal
Molecular weight:
134.14
Ref: 3B-A1585
1g | 534.00 € | ||
100mg | 90.00 € |
Estimated delivery in United States, on Tuesday 25 Feb 2025

Ref: IN-DA001SG6
1g | 590.00 € | ||
100mg | 120.00 € | ||
250mg | 188.00 € |
Estimated delivery in United States, on Tuesday 4 Mar 2025

Ref: 10-F690272
100mg | 124.00 € |
Estimated delivery in United States, on Friday 7 Mar 2025

2-Aminobenzotriazole
CAS:1614-11-5
2-Aminobenzotriazole is a compound that can exist in two different forms, which are called polymorphs. …
Formula:
C6H6N4
Purity:
Min. 95%
Molecular weight:
134.14 g/mol
Ref: 3D-BAA61411
1g | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |